首页> 外文期刊>Signal transduction and targeted therapy. >USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia
【24h】

USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia

机译:USP7去泛素化并稳定NOTCH1在T细胞急性淋巴细胞白血病中

获取原文
           

摘要

T-cell acute lymphoblastic leukemia (T-ALL) is a highly aggressive leukemia that is primarily caused by aberrant activation of the NOTCH1 signaling pathway. Recent studies have revealed that posttranslational modifications, such as ubiquitination, regulate NOTCH1 stability, activity, and localization. However, the specific deubiquitinase that affects NOTCH1 protein stability remains unestablished. Here, we report that ubiquitin-specific protease 7 (USP7) can stabilize NOTCH1. USP7 deubiquitinated NOTCH1 in vivo and in vitro, whereas knockdown of USP7 increased the ubiquitination of NOTCH1. USP7 interacted with NOTCH1 protein in T-ALL cells, and the MATH and UBL domains of USP7 were responsible for this interaction. Depletion of USP7 significantly suppressed the proliferation of T-ALL cells in vitro and in vivo, accompanied by downregulation of the NOTCH1 protein level. Similarly, pharmacologic inhibition of USP7 led to apoptosis of T-ALL cells. More importantly, we found that USP7 was significantly upregulated in human T-ALL cell lines and patient samples, and a USP7 inhibitor exhibited cell cytotoxicity toward primary T-ALL cells, indicating the clinical relevance of these findings. Overall, our results demonstrate that USP7 is a novel deubiquitinase that stabilizes NOTCH1. Therefore, USP7 may be a promising therapeutic target in the currently incurable T-ALL.
机译:T细胞急性淋巴细胞白血病(T-ALL)是一种高度侵袭性白血病,主要由NOTCH1信号通路的异常激活引起。最近的研究表明,翻译后修饰(例如泛素化)调节NOTCH1的稳定性,活性和定位。但是,影响NOTCH1蛋白稳定性的特定去泛素酶仍未确定。在这里,我们报告泛素特异性蛋白酶7(USP7)可以稳定NOTCH1。 USP7在体内和体外使NOTCH1泛素化,而敲除USP7则增加了NOTCH1的泛素化。 USP7与T-ALL细胞中的NOTCH1蛋白相互作用,而USP7的MATH和UBL结构域负责这种相互作用。 USP7的耗竭显着抑制了T-ALL细胞在体外和体内的增殖,并伴随着NOTCH1蛋白水平的下调。同样,USP7的药理抑制作用导致T-ALL细胞凋亡。更重要的是,我们发现USP7在人T-ALL细胞系和患者样品中显着上调,并且USP7抑制剂对原代T-ALL细胞表现出细胞毒性,表明这些发现在临床上具有相关性。总体而言,我们的结果表明,USP7是一种新型的去泛素酶,可稳定NOTCH1。因此,USP7可能是目前无法治愈的T-ALL中有希望的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号